Metabolism Of Pltp, Cetp, And Lcat On Multiple Hdl Sizes Using The Orbitrap Fusion Lumos

In this study, we demonstrate that the Orbitrap Lumos can measure tracer in proteins whose abundances are 1000s-fold less than APOA1, specifically the lipid transfer proteins phospholipid transfer protein (PLTP), cholesterol ester transfer protein (CETP), and lecithin-cholesterol acyl transferase (LCAT). Relative to the Q Exactive. the Lumos improved tracer detection by reducing tracer enrichment compression, thereby providing consistent enrichment data across multiple HOL sizes from 6 participants. We determined by compartmental modeling that PLTP is secreted in medium and large HIM (alpha2, alphal, and alpha0) and is transferred from medium to larger sizes during circulation from where it is catabolized. CETP is secreted mainly in alphal and alpha2 and remains in these sizes during circulation. LCAT is secreted mainly in medium and small HOL (alpha2, alpha3, prebeta). Unlike PLTP and CETP, LCAT's appearance on HDL is markedly delayed, indicating that LCAT may reside for a time outside of systemic circulation before attaching to HOL in plasma. The determination of these lipid transfer proteins' unique metabolic structures was possible due to advances in MS technologies.